Immunotherapy and chemo before surgery for salivary gland cancer
Part of Cancer, Ear, nose & throat clinical trials.
This trial tests an immunotherapy drug (toripalimab) with chemotherapy before surgery for salivary gland cancer. It aims to shrink the tumor to make surgery more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a type of salivary gland cancer that is planned for surgery with a goal to cure (like mucoepidermoid, adenocarcinoma, adenoid cystic, or acinic cell).
- You are between 18 and 79 years old.
- You are generally well and able to care for yourself (ECOG 0 or 1).
- You have not had immunotherapy before.
- Your recent blood tests show good kidney, liver, and bone marrow function.
- You are willing to use birth control during and for a few months after the study, if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies giving an immunotherapy drug (sintilimab) plus two chemotherapy medicines before surgery to shrink salivary gland cancer. The goal is to improve how well the cancer responds and is controlled, while still aiming for a cure through surgery.
This trial tests toripalimab (an immunotherapy) given before surgery for untreated head and neck squamous cell carcinoma, either alone or with chemotherapy. The goal is to shrink or control the cancer earlier and see if it improves outcomes for people who plan curative surgery.
This trial tests whether adding a type of radiation therapy (SBRT) to chemoimmunotherapy before surgery helps people with advanced mouth or throat cancer. The goal is to see if this combination can shrink tumors more effectively and improve outcomes.
This Phase 2 trial tests giving the immunotherapy drug sintilimab before surgery, along with fewer chemotherapy cycles. The goal is to shrink or control oral or throat squamous cell cancers while keeping side effects lower, before the tumor is removed.
This trial tests whether giving immunotherapy (sintilimab) together with chemotherapy before surgery can help treat oral cavity cancer. The goal is to shrink the tumor and possibly improve outcomes for patients with early-stage cancer that hasn't spread.
This trial tests a personalized treatment approach for recurrent or metastatic salivary gland cancer. It uses special tests on your tumor to find the best targeted therapy for your specific cancer type.
Hear when a new Salivary Gland Malignant Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.